Limited yield of SARS-CoV-2 screening in asymptomatic hematopoietic cell transplant and chimeric antigen receptor T-cell therapy patients
Early in the COVID-19 pandemic, screening was initiated in several settings to mitigate asymptomatic transmission of SARS-CoV-2. However, this practice was later discouraged by the Society for Healthcare Epidemiology of America. This single-center retrospective study demonstrates limited utility of SARS-CoV-2 screening tests in asymptomatic HCT and CAR T-cell patients.
Authors
- Joshua A. Hill (ORCID: https://orcid.org/0000-0002-3617-6142)
- Marco Mielcarek (ORCID: https://orcid.org/0000-0002-5680-8688)
- Marie H. Wilson (ORCID: https://orcid.org/0000-0002-3827-0159)
- Denise J. McCulloch (ORCID: https://orcid.org/0000-0001-8755-6105)
- Steven A. Pergam (ORCID: https://orcid.org/0000-0002-6333-5196)
- Michelle Swetky (ORCID: https://orcid.org/0009-0001-0687-920X)
- Elizabeth M. Krantz
- Suni Elgar
- Catherine Liu (ORCID: https://orcid.org/0000-0002-7532-4822)
- Emily A. Rosen (ORCID: https://orcid.org/0000-0002-1378-8859)
- Seth Cohen (ORCID: https://orcid.org/0000-0003-0064-2735)
Institutions
- Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA)
- University of Washington (US)
- Fred Hutch Cancer Center (US)
Publication Details
- Journal
- Antimicrobial Stewardship & Healthcare Epidemiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/ash.2025.10112
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00